NCT04565444

Brief Summary

Ketones are natural substances normally produced by the body during prolonged fasting and starvation, or in response to a "ketogenic" diet to be used as fuel by the brain and muscles. Ketones are therefore similar to dietary proteins, carbohydrates and fats since they represent a source of energy for the body. In addition to serving as a source of energy, ketones have also been shown to stimulate increased rates of muscle protein synthesis in humans. The ingestion of dietary protein is well established to stimulate an increase in the rate of protein synthesis in skeletal muscle. The rate of muscle protein synthesis can be maximized following the intake of 20g of protein. As a result, smaller doses of protein (i.e. 10g) represent a sub-optimal dose of protein because there is still room for improvement concerning muscle protein synthesis. Recently ketone-containing food products have become available that elevate ketone levels in the body without the need for ketogenic diets or prolonged fasting. Therefore, the purpose of this study is to measure skeletal muscle protein synthesis rates after ingesting the following:

  1. 1.Ketone monoester
  2. 2.Ketone monoester supplemented with sub-optimal dose of whey protein
  3. 3.Sub-optimal dose of whey protein

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

September 21, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 25, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 14, 2021

Completed
Last Updated

May 18, 2021

Status Verified

May 1, 2021

Enrollment Period

8 months

First QC Date

September 17, 2020

Last Update Submit

May 17, 2021

Conditions

Keywords

ketoneprotein metabolismmuscle

Outcome Measures

Primary Outcomes (1)

  • Fractional synthetic rate of muscle protein synthesis (myofibrillar)

    0-5 hours in the post-prandial period

Secondary Outcomes (7)

  • Fractional synthetic rate of muscle protein synthesis (myofibrillar)

    0-3 hours in the pre-prandial period; 0-2 hours, and 2-5 hours into the post-prandial period

  • Plasma enrichments (in moles percent excess) of L-[ring-2H5]-phenylalanine

    3 hours pre-prandial to 5 hours post-prandial

  • Plasma glucose concentration (mmol/L)

    3 hours pre-prandial to 5 hours post-prandial

  • Plasma insulin concentration (pmol/L)

    3 hours pre-prandial to 5 hours post-prandial

  • Plasma amino acid concentrations (mmol/L)

    3 hours pre-prandial to 5 hours post-prandial

  • +2 more secondary outcomes

Study Arms (3)

Ketone

EXPERIMENTAL

Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and carbohydrate control.

Dietary Supplement: Ketone

Ketone + Protein

EXPERIMENTAL

Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and 10g of whey protein.

Dietary Supplement: Ketone + Protein

Protein

EXPERIMENTAL

Carbohydrate control and 10g of whey protein.

Dietary Supplement: Protein

Interventions

KetoneDIETARY_SUPPLEMENT

* Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) * Isocaloric carbohydrate control: dextrose + vanilla flavouring

Ketone
Ketone + ProteinDIETARY_SUPPLEMENT

* Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) * 10g Whey Protein * L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)

Ketone + Protein
ProteinDIETARY_SUPPLEMENT

* Isocaloric carbohydrate control: dextrose + stevia * 10g Whey Protein * L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)

Protein

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male
  • Aged between 18-35 years inclusive
  • Healthy, moderately active
  • BMI \< 30 kg/m2 and \> 18.5 kg/m2
  • Having given informed consent

You may not qualify if:

  • Presence of any identified metabolic or intestinal disorders
  • Use of tobacco products
  • Allergies to milk proteins (whey or casein)
  • Lactose intolerance
  • Phenylketonuria (PKU)
  • A history of neuromuscular problems
  • Previous participation in amino acid tracer studies
  • Adherence to a strict vegetarian or vegan diet
  • Current use of ketone supplements or adherence to a ketogenic diet
  • Use of medications known to affect protein metabolism
  • Diagnosis of Diabetes
  • Engagement in sports or physical exercise 5 or more days per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Exercise Metabolism and Nutrition Research Laboratory

Montreal, Quebec, H2W 1S4, Canada

Location

Related Publications (1)

  • Hannaian SJ, Lov J, Hawley SE, Dargegen M, Malenda D, Gritsas A, Gouspillou G, Morais JA, Churchward-Venne TA. Acute ingestion of a ketone monoester, whey protein, or their co-ingestion in the overnight postabsorptive state elicit a similar stimulation of myofibrillar protein synthesis rates in young males: a double-blind randomized trial. Am J Clin Nutr. 2024 Mar;119(3):716-729. doi: 10.1016/j.ajcnut.2024.01.004. Epub 2024 Jan 11.

MeSH Terms

Conditions

Ketosis

Interventions

KetonesProteins

Condition Hierarchy (Ancestors)

AcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Organic ChemicalsAmino Acids, Peptides, and Proteins

Study Officials

  • Tyler A Churchward-Venne, Ph.D.

    McGill University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Tyler A. Churchward-Venne, Ph.D., Assistant Professor, McGill University

Study Record Dates

First Submitted

September 17, 2020

First Posted

September 25, 2020

Study Start

September 21, 2020

Primary Completion

May 14, 2021

Study Completion

May 14, 2021

Last Updated

May 18, 2021

Record last verified: 2021-05

Locations